Braveheart Bio is a clinical-stage biopharmaceutical company developing therapies for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Its lead candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor being developed for obstructive and non-obstructive HCM. The Director/Senior Director of Clinical Quality will be a senior quality leader responsible for clinical quality oversight and inspection readiness for Braveheart Bio’s late-stage HCM clinical program. Reporting to the Vice President, Quality, this person will establish and execute the clinical oversight framework for global Phase 3 development, guide clinical development teams, and prepare the organization for future regulatory submissions and commercialization. The role partners closely with Clinical Operations, Regulatory, Biometrics, Pharmacovigilance, and external CRO and vendor partners. The position may build and lead a small quality team as the company grows. It is a hands-on, strategic, foundational role at a lean biotech entering late-stage development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior